{"company": {"org_id": "T001669239", "org_name_cn": "普蕊斯(上海)医药科技开发股份有限公司", "org_short_name_cn": "普蕊斯", "org_name_en": "Smo Clinplus Co.,Ltd.", "org_short_name_en": "ClinPlus", "main_operation_business": "向国内外制药公司、医疗器械公司及部分健康相关产品的临床研究开发提供SMO服务。", "operating_scope": "　　从事医药领域领域技术开发、技术转让、技术咨询、技术服务，从事货物及技术的进出口业务。【依法须经批准的项目，经相关部门批准后方可开展经营活动】", "district_encode": "310101", "org_cn_introduction": "普蕊斯(上海)医药科技开发股份有限公司的主营业务是向国内外制药公司、医疗器械公司及部分健康相关产品的临床研究开发提供SMO服务。公司的主要产品是SMO业务。普蕊斯（上海）医药科技开发股份有限公司于2023年11月15日取得“高新技术企业证书”。", "legal_representative": "赖春宝", "general_manager": "杨宏伟", "secretary": "赖小龙", "established_date": 1361462400000, "reg_asset": 79004770.0, "staff_num": 4416, "telephone": "86-21-60755800", "postcode": "200001", "fax": "86-21-60755803", "email": "ir@smo-clinplus.com", "org_website": "www.smo-clinplus.com", "reg_address_cn": "上海市黄浦区思南路105号1号楼108室", "reg_address_en": null, "office_address_cn": "上海市黄浦区广东路500号世界贸易大厦23层", "office_address_en": null, "currency_encode": "019001", "currency": "CNY", "listed_date": 1652716800000, "provincial_name": "上海市", "actual_controller": "赖春宝 (33.21%)", "classi_name": "民营企业", "pre_name_cn": null, "chairman": "赖春宝", "executives_nums": 17, "actual_issue_vol": 15000000.0, "issue_price": 46.8, "actual_rc_net_amt": 630367557.0, "pe_after_issuing": 48.75, "online_success_rate_of_issue": 0.01703858, "affiliate_industry": {"ind_code": "BK0075", "ind_name": "医疗服务"}}}